Atezolizumab in non-squamous non-small cell lung cancer

被引：5
|
作者：
Akamine, Takaki [1 ]
Toyokawa, Gouji [1 ]
Tagawa, Tetsuzo [1 ]
Seto, Takashi [2 ]
机构：
[1] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan
[2] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Minami Ku, Fukuoka, Fukuoka, Japan
来源：
JOURNAL OF THORACIC DISEASE | 2018年 / 10卷
关键词：
OPEN-LABEL; 1ST-LINE THERAPY; PHASE-2; TRIAL; EGFR; IMMUNOTHERAPY; PEMBROLIZUMAB; MULTICENTER; BEVACIZUMAB; CHEMOTHERAPY; DOCETAXEL;
D O I：
10.21037/jtd.2018.07.92
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：S3155 / S3159
页数：5
相关论文
共 50 条
  • [41] Immunotherapy for non-small cell lung cancer
    Vafadar, Sam
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2019, 32 (09): : 37 - 42
  • [42] Histological comparison between preoperative and surgical specimens of non-small cell lung cancer for distinguishing between "squamous" and "non-squamous" cell carcinoma
    Yamagishi, Tomoko
    Shimizu, Katsuhiko
    Ochi, Nobuaki
    Yamane, Hiromichi
    Irei, Isao
    Sadahira, Yoshito
    Takigawa, Nagio
    Oka, Mikio
    Nakata, Masao
    DIAGNOSTIC PATHOLOGY, 2014, 9
  • [43] Molecular analysis of peripheral non-squamous non-small cell lung cancer sampled by radial EBUS
    Guisier, Florian
    Salauen, Mathieu
    Lachkar, Samy
    Lamy, Aude
    Piton, Nicolas
    Obstoy, Berengere
    Sabourin, Jean-Christophe
    Thiberville, Luc
    RESPIROLOGY, 2016, 21 (04) : 718 - 726
  • [44] Prognostic value of Beclin 1, EGFR and ALK in non-squamous non-small cell lung cancer
    Yanhui Wan
    Youhui Qian
    Youyu Wang
    Fuyuan Fang
    Guodong Wu
    Discover Oncology, 13
  • [45] PemetrexedA Review of its Use in the Management of Advanced Non-Squamous Non-Small Cell Lung Cancer
    Claudine M. Baldwin
    Caroline M. Perry
    Drugs, 2009, 69 : 2279 - 2302
  • [46] A prospective cohort study of patients with non-squamous non-small cell lung cancer treated with bevacizumab
    Naoki, Katsuhiko
    Takeda, Yuichiro
    Soejima, Kenzo
    Arai, Daisuke
    Naka, Go
    Nagase, Seisuke
    Arirnura, Ken
    Kanemura, Toshinori
    Ohhira, Tatsuo
    Ikeda, Norihiko
    ONCOLOGY LETTERS, 2017, 13 (05) : 3285 - 3290
  • [47] Expanded molecular interrogation for potential actionable targets in non-squamous non-small cell lung cancer
    Lau, Kah Weng
    Seng, Claudia
    Lim, Tony K. H.
    Tan, Daniel S. W.
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (18)
  • [48] Specific Adverse Effects of Bevacizumab in the Treatment of Non-Squamous Non-Small Cell Lung Cancer (NSCLC) in Clinical Practice
    Mazilu, Laura
    Stanculeanu, Dana Lucia
    Gheorghe, Andreea Daniela
    Suceveanu, Adrian Paul
    Hainarosie, Razvan
    Parepa, Irinel Raluca
    Bratu, Ovidiu
    Diaconu, Camelia Cristina
    Manuc, Daniela
    Stoian, Anca Pantea
    Suceveanu, Andra Iulia
    REVISTA DE CHIMIE, 2018, 69 (12): : 3644 - 3647
  • [49] Addition of atezolizumab to nab-paclitaxel plus carboplatin is a new standard option for the first-line treatment for non-squamous non-small cell lung cancer
    Yamaguchi, Teppei
    Hida, Toyoaki
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (08) : E11 - E14
  • [50] Prognostic value of Beclin 1, EGFR and ALK in non-squamous non-small cell lung cancer
    Wan, Yanhui
    Qian, Youhui
    Wang, Youyu
    Fang, Fuyuan
    Wu, Guodong
    DISCOVER ONCOLOGY, 2022, 13 (01)
12345